Literature DB >> 8484657

Occlusion therapy of Japanese children with anisometropic amblyopia without strabismus.

S Noda1, S Hayasaka, T Setogawa.   

Abstract

We examined 38 children (20 boys and 18 girls) with anisometropic amblyopia without strabismus who had been treated with occlusion therapy. At the initial visit, their ages ranged from five to ten years. Their visual acuity scores improved after therapy, and this was unrelated to patient age. The amount of anisometropia, visual acuity at the initial visit, and compliance were related to improved visual acuity in the amblyopic eye. The visual acuity improved for six months after therapy. No further gains were detected thereafter.

Entities:  

Mesh:

Year:  1993        PMID: 8484657

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  6 in total

1.  The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

Authors:  J T Flynn; G Woodruff; J R Thompson; F Hiscox; W Feuer; J Schiffman; A Corona; L K Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies.

Authors:  J T Flynn; J Schiffman; W Feuer; A Corona
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  Parental non-concordance with occlusion therapy.

Authors:  D Newsham
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

4.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

5.  A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy.

Authors:  D Newsham
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

6.  Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: a randomized controlled trial.

Authors:  Prachee Vasant Pawar; Sachin S Mumbare; Mrunal Suresh Patil; Seema Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.